Scotia Capital’s Sanofi SNY Stock Holding History

Scotia Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,492	Closed	-$218K	–	975
2025 Q4	$218K	Sell	4,492 -192	-4%	-$9.52K	﹤0.01%	829
2025 Q3	$221K	Sell	4,684 -1,601	-25%	-$77.3K	﹤0.01%	823
2025 Q2	$304K	Sell	6,285 -1,840	-23%	-$94K	﹤0.01%	719
2025 Q1	$451K	Sell	8,125 -552	-6%	-$29.9K	﹤0.01%	631
2024 Q4	$419K	Buy	8,677 +572	+7%	+$29.1K	﹤0.01%	648
2024 Q3	$467K	Sell	8,105 -518	-6%	-$28K	﹤0.01%	630
2024 Q2	$418K	Sell	8,623 -1,738	-17%	-$83.8K	﹤0.01%	628
2024 Q1	$504K	Sell	10,361 -3,050	-23%	-$149K	﹤0.01%	596
2023 Q4	$667K	Buy	13,411 +8,735	+187%	+$427K	﹤0.01%	531
2023 Q3	$251K	Sell	4,676 -476	-9%	-$25.4K	﹤0.01%	679
2023 Q2	$278K	Sell	5,152 -17,404	-77%	-$936K	﹤0.01%	665
2023 Q1	$1.23M	Sell	22,556 -2,506	-10%	-$122K	0.01%	414
2022 Q4	$1.21M	Sell	25,062 -1,059	-4%	-$46.5K	0.01%	420
2022 Q3	$993K	Sell	26,121 -1,556	-6%	-$69.3K	0.01%	456
2022 Q2	$1.39M	Sell	27,677 -2,143	-7%	-$114K	0.01%	414
2022 Q1	$1.53M	Sell	29,820 -3,425	-10%	-$177K	0.01%	439
2021 Q4	$1.67M	Sell	33,245 -2,297	-6%	-$114K	0.01%	441
2021 Q3	$1.71M	Buy	35,542 +362	+1%	+$18.4K	0.01%	426
2021 Q2	$1.85M	Sell	35,180 -393	-1%	-$20.5K	0.01%	404
2021 Q1	$1.76M	Sell	35,573 -1,245	-3%	-$59.8K	0.01%	376
2020 Q4	$1.79M	Sell	36,818 -176	-0.5%	-$8.68K	0.02%	346
2020 Q3	$1.86M	Buy	36,994 +370	+1%	+$19K	0.02%	304
2020 Q2	$1.87M	Sell	36,624 -2,168	-6%	-$105K	0.03%	271
2020 Q1	$1.7M	Sell	38,792 -1,455	-4%	-$69.6K	0.02%	269
2019 Q4	$2.02M	Buy	40,247 +21	+0.1%	+$984	0.02%	290
2019 Q3	$1.86M	Sell	40,226 -1,753	-4%	-$75.6K	0.02%	297
2019 Q2	$1.82M	Sell	41,979 -3,731	-8%	-$159K	0.02%	305
2019 Q1	$2.02M	Sell	45,710 -1,029	-2%	-$44.1K	0.03%	271
2018 Q4	$2.03M	Buy	46,739 +1,066	+2%	+$47K	0.03%	262
2018 Q3	$2.04M	Sell	45,673 -1,966	-4%	-$84K	0.03%	286
2018 Q2	$1.89M	Hold	47,639	–	–	0.03%	291
2018 Q1	$1.91M	Sell	47,639 -1,134	-2%	-$47.2K	0.03%	293
2017 Q4	$2.1M	Sell	48,773 -847	-2%	-$39.1K	0.03%	286
2017 Q3	$2.47M	Buy	49,620 +1,580	+3%	+$76.5K	0.04%	256
2017 Q2	$2.3M	Sell	48,040 -3,111	-6%	-$149K	0.04%	230
2017 Q1	$2.32M	Buy	51,151 +1,580	+3%	+$67K	0.04%	245
2016 Q4	$2.01M	Buy	49,571 +12,910	+35%	+$509K	0.03%	294
2016 Q3	$1.4M	Buy	36,661 +4,150	+13%	+$167K	0.03%	355
2016 Q2	$1.37M	Sell	32,511 -2,606	-7%	-$107K	0.03%	335
2016 Q1	$1.41M	Sell	35,117 -2,880	-8%	-$116K	0.03%	299
2015 Q4	$1.77M	Hold	37,997	–	–	0.04%	298
2015 Q3	$1.81M	Sell	37,997 -2,208	-5%	-$112K	0.04%	273
2015 Q2	$1.99M	Buy	40,205 +8,405	+26%	+$426K	0.04%	281
2015 Q1	$1.57M	Buy	31,800 +2,909	+10%	+$139K	0.04%	257
2014 Q4	$1.31M	Buy	28,891 +11,530	+66%	+$559K	0.03%	258
2014 Q3	$978K	Sell	17,361 -554	-3%	-$29.8K	0.02%	308
2014 Q2	$954K	Sell	17,915 -3,065	-15%	-$163K	0.02%	305
2014 Q1	$1.09M	Buy	20,980 +999	+5%	+$50.6K	0.02%	282
2013 Q4	$1.07M	Buy	19,981 +1,480	+8%	+$76.4K	0.03%	260
2013 Q3	$937K	Buy	18,501 +6,290	+52%	+$320K	0.03%	263
2013 Q2	$628K	Buy	+12,211	New	+$651K	0.02%	271

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Scotia Capital's SNY Position: Q1 2026 in Review

Scotia Capital sold out of Sanofi (SNY) in Q1 2026, closing a stake of 4,492 shares — an estimated $218K sold.

Scotia Capital first reported a position in SNY in Q2 2013 and held it in 51 quarters. The position peaked at $2.47M in Q3 2017. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Scotia Capital reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
Scotia Capital sold 4,492 Sanofi shares in Q1 2026, an estimated $218K.
Scotia Capital first reported a position in Sanofi in Q2 2013 and held it in 51 quarters.
Scotia Capital's Sanofi position peaked at $2.47M in Q3 2017.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.